Document Detail


DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.
MedLine Citation:
PMID:  11892070     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
DiGeorge syndrome is characterized by conotruncal cardiac defects, hypocalcemia, and a hypoplastic thymus. Many, but not all, patients have a heterozygous deletion of chromosome 22q11.2. In its most severe form, it represents a devastating syndrome with high mortality. Patients with severe immunodeficiency are candidates for a thymic transplant or a fully matched bone marrow transplant. Fortunately, the majority of patients with either DiGeorge syndrome or chromosome 22q11.2 deletion syndrome have a mild to moderate immunodeficiency. These patients may develop recurrent infections or autoimmune disease.
Authors:
K E Sullivan
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current allergy and asthma reports     Volume:  1     ISSN:  1529-7322     ISO Abbreviation:  Curr Allergy Asthma Rep     Publication Date:  2001 Sep 
Date Detail:
Created Date:  2002-03-14     Completed Date:  2002-04-10     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  101096440     Medline TA:  Curr Allergy Asthma Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  438-44     Citation Subset:  IM    
Affiliation:
Division of Immunologic and Infectious Diseases, Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA. sullivak@mail.med.upenn.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chromosome Deletion*
Chromosomes, Human, Pair 22* / immunology
DiGeorge Syndrome / epidemiology,  immunology*,  therapy
Humans
Immunologic Deficiency Syndromes / epidemiology,  immunology,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Wiskott-Aldrich syndrome.
Next Document:  The hyper IgM syndrome.